Curative Biosciences, Inc. is engaged in the development and marketing of novel therapeutics. The company is headquartered in Miami, Florida. The company went IPO on 2004-08-26. The Company’s product segment is focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The firm through its consumer products business manufactures market and sells consumer products containing plant-based CBD under the brand Curative Biosciences.
Follow-Up Questions
Qui est le CEO de Curative Biosciences Inc ?
Richard Damion est le Chief Executive Officer de Curative Biosciences Inc, il a rejoint l'entreprise depuis 2013.
Quelle est la performance du prix de l'action CBDX ?
Le prix actuel de CBDX est de $0.0001, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Curative Biosciences Inc ?
Curative Biosciences Inc appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quelle est la capitalisation boursière de Curative Biosciences Inc ?
La capitalisation boursière actuelle de Curative Biosciences Inc est de $3157
